Expert discussion on the updated IPF treatment guidelines in 2015
The first clinical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis (IPF)1 were published in 2011. In July 2015, the treatment recommendations were updated according to evidence reported since the publication of the prior guidelines.2
Learn about the guidelines update
The two expert speakers Prof. Jürgen Behr (University of Munich, Germany) and Prof. Carlo Vancheri (University of Catania, Italy) explain the changes made to the guidelines and discuss implications of the update for clinical practice.
The IPF webinars are interactive online meetings for healthcare professionals interested in idiopathic pulmonary fibrosis (IPF). They are organised by Boehringer Ingelheim with the aim of providing physicians with the latest information regarding the management of patients with IPF. During these events, expert speakers present clinical trial data, discuss treatment options, and review IPF patient cases.
Don’t miss the opportunity to watch the webinar sessions in the Learning Center of the product website!
- Raghu G., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824.
- Raghu G., et al. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med 2015;192:e3–e19.